|
|
||||||||
EPIDEMIOLOGY |
Laboratory of Enteric Pathogens, Division of Gastrointestinal Infections, Central Public Health Laboratory and *Communicable Disease Surveillance Centre, London NW9 5HT
Corresponding author: Dr G. A. Willshaw (e-mail: gsmith{at}phls.nhs.uk).
Date received 1 Feb. 2000; revised version received 9 June 2000; accepted 11 June 2000.
Abstract
A total of 3429 isolations of verocytotoxin-producing Escherichia coli O157 (VTEC O157) was confirmed from human sources in England and Wales during the period 19951998. The largest annual total was 1087 in 1997. Most infections occurred in the third quarter of each year. The overall rate of infection ranged from 1.28 to 2.10/100 000 population and showed regional variation. The highest incidence was in children aged 14 years. Annually, between 5% and 11% of strains were from patients who had travelled abroad. There were 67 general outbreaks of infection represented by 407 (11.9%) VTEC O157 isolates. Outbreaks involved transmission by contaminated food or water, person-to-person spread and direct or indirect animal contact, and five were associated with foreign travel. The majority (76%) of strains carried verocytotoxin (VT) 2 genes and 23.3% were VT1+VT2. Most strains had the flagellar antigen H7, but c. 14% were non-motile. Approximately 20% of isolates were resistant to antimicrobial agents, predominantly streptomycin, sulphonamides and tetracycline. In addition to VTEC O157, strains of serogroup O157 that did not possess VT genes were identified. These were either derivatives of VTEC O157 that had lost VT genes or were strains with H antigens other than H7 that have never been associated with VT production. Strains of VTEC other than O157 were characterised. Most were associated with diarrhoea, bloody diarrhoea or haemolytic uraemic syndrome and had virulence markers in addition to VT.
This article has been cited by other articles:
![]() |
E. Strauch, J. A. Hammerl, A. Konietzny, S. Schneiker-Bekel, W. Arnold, A. Goesmann, A. Puhler, and L. Beutin Bacteriophage 2851 Is a Prototype Phage for Dissemination of the Shiga Toxin Variant Gene 2c in Escherichia coli O157:H7 Infect. Immun., December 1, 2008; 76(12): 5466 - 5477. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagachinta and J. Chen Transfer of Class 1 Integron-Mediated Antibiotic Resistance Genes from Shiga Toxin-Producing Escherichia coli to a Susceptible E. coli K-12 Strain in Storm Water and Bovine Feces Appl. Envir. Microbiol., August 15, 2008; 74(16): 5063 - 5067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Shaw, C. N. Berger, B. Feys, S. Knutton, M. J. Pallen, and G. Frankel Enterohemorrhagic Escherichia coli Exploits EspA Filaments for Attachment to Salad Leaves Appl. Envir. Microbiol., May 1, 2008; 74(9): 2908 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Milnes, G. C. Pritchard, K. Sprigings, R. Futter, and G. A. Willshaw Verocytotoxin-producing E coli O26 infection in calves Vet Rec., July 29, 2006; 159(5): 159 - 159. [Full Text] [PDF] |
||||
![]() |
M. C. Pearce, J. Evans, I. J. McKendrick, A. W. Smith, H. I. Knight, D. J. Mellor, M. E. J. Woolhouse, G. J. Gunn, and J. C. Low Prevalence and Virulence Factors of Escherichia coli Serogroups O26, O103, O111, and O145 Shed by Cattle in Scotland Appl. Envir. Microbiol., January 1, 2006; 72(1): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jenkins, N. T. Perry, T. Cheasty, D. J. Shaw, G. Frankel, G. Dougan, G. J. Gunn, H. R. Smith, A. W. Paton, and J. C. Paton Distribution of the saa Gene in Strains of Shiga Toxin-Producing Escherichia coli of Human and Bovine Origins J. Clin. Microbiol., April 1, 2003; 41(4): 1775 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bettelheim, M. A. Hornitzky, S. P. Djordjevic, and A. Kuzevski Antibiotic resistance among verocytotoxigenic Escherichia coli (VTEC) and non-VTEC isolated from domestic animals and humans J. Med. Microbiol., February 1, 2003; 52(2): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. CHART, T. CHEASTY, and G. A. WILLSHAW Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli J. Med. Microbiol., December 1, 2002; 51(12): 1050 - 1054. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |